C Z, Nikolic-Vukosavljevic D, Brankovic-Magic M, Kanjer K, Gavrilovic D, Mitrovic L, Borojevic N, Vukotic D, Spuzic I: Expression of epidermal growth issue receptor in breast cancer, from early stages to advanced disease. J Exp Clin Cancer Res 1999, 18:347?55. 36. Dunkern TR, Fritz G, Kaina B: Ultraviolet light-induced DNA harm triggers apoptosis in nucleotide excision repair-deficient cells through Bcl-2 decline and caspase-3/-8 activation. Oncogene 2001, 20:6026?038. 37. Kulms D, Poppelmann B, Yarosh D, Luger TA, Krutmann J, Schwarz T: Nuclear and cell membrane effects contribute independently for the induction of apoptosis in human cells exposed to UVB radiation. Proc Natl Acad Sci U S A 1999, 96:7974?979. 38. Murahashi H, Azuma H, Zamzami N, Furuya KJ, Ikebuchi K, Yamaguchi M, Yamada Y, Sato N, Fujihara M, Kroemer G, Ikeda H: Doable contribution of apoptosis-inducing factor (AIF) and reactive oxygen species (ROS) to UVB-induced caspase-independent cell death within the T cell line Jurkat. J Leukoc Biol 2003, 73:399?06. 39. Maeda T, Chua PP, Chong MT, Sim AB, Nikaido O, Tron VA: Nucleotide excision repair genes are upregulated by low-dose artificial ultraviolet B: evidence of a photoprotective SOS response? J Invest Dermatol 2001, 117:1490?497. 40. Owen JB, Coia LR, Hanks GE: Current patterns of growth in radiation therapy facilities in the Usa: a patterns of care study report. Int J Radiat Oncol Biol Phys 1992, 24:983?86. 41. McGinn CJ, Lawrence TS: Recent advances within the use of radiosensitizing nucleosides. Semin Radiat Oncol 2001, 11:270?80. 42. Wurschmidt F, Dahle J, Petersen C, Wenzel C, Kretschmer M, Bastian C: Reirradiation of recurrent breast cancer with and without concurrent chemotherapy. Radiat Oncol 2008, 3:28. 43. Kao J, Conzen SD, Jaskowiak NT, Song DH, Recant W, Singh R, Masters GA, Fleming GF, Heimann R: Concomitant radiation therapy and paclitaxel for unresectable locally advanced breast cancer: results from two consecutive phase I/II trials. Int J Radiat Oncol Biol Phys 2005, 61:1045?053. 44. Scappaticci FA: Mechanisms and future directions for angiogenesis-based cancer therapies. J Clin Oncol 2002, 20:3906?927. 45. Gorski DH, Mauceri HJ, Salloum RM, Gately S, Hellman S, Beckett MA, Sukhatme VP, Soff GA, Kufe DW, Weichselbaum RR: Potentiation in the antitumor impact of ionizing radiation by short concomitant exposures to angiostatin. Cancer Res 1998, 58:5686?689. 46. Griffin RJ, Williams BW, Wild R, Cherrington JM, Park H, Song CW: Simultaneous inhibition with the receptor kinase activity of vascular endothelial, fibroblast, and platelet-derived development elements suppresses tumor growth and enhances tumor radiation response.1,2,3,4-Tetrahydro-1,5-naphthyridine Purity Cancer Res 2002, 62:1702?706.55477-80-0 manufacturer 47.PMID:35954127 Wondrak GT, Jacobson MK, Jacobson EL: Endogenous UVA-photosensitizers: mediators of skin photodamage and novel targets for skin photoprotection. Photochem Photobiol Sci 2006, five:215?37. 48. Weischer M, Blum A, Eberhard F, Rocken M, Berneburg M: No proof for enhanced skin cancer risk in psoriasis individuals treated with broadband or narrowband UVB phototherapy: a initial retrospective study. Acta Derm Venereol 2004, 84:370?74. 49. Hirakawa S, Fujii S, Kajiya K, Yano K, Detmar M: Vascular endothelial growth factor promotes sensitivity to ultraviolet B-induced cutaneous photodamage. Blood 2005, 105:2392?399. 50. Sasaki K, Tsuno NH, Sunami E, Kawai K, Shuno Y, Hongo K, Hiyoshi M, Kaneko M, Murono K, Tada N, et al: Radiosensitization of human breast cancer cells to ul.